Results 201 to 210 of about 55,457 (295)

Cell atlases and the developmental foundations of the phenotype. [PDF]

PLoS Comput Biol
Lou A, Chagoyen M, Poyatos JF.
europepmc   +1 more source

Current landscape of single-cell genomics in meningioma. [PDF]

Neurooncol Adv
Ellenbogen Y, Landry AP, Yefet LS, Ajisebutu A, Gui C, Persaud P, Kaloti R, Nassiri F.   +7 more
europepmc   +1 more source

Interleaving cortex-analog mixing improves deep non-negative matrix factorization networks. [PDF]

Front Comput Neurosci
Nouri M, Rotermund D, Garcia-Ortiz A, Pawelzik KR.   +3 more
europepmc   +1 more source

Skin Barrier Biomarkers in Patch-Induced and Clinical Allergic and Irritant Contact Dermatitis. [PDF]

Contact Dermatitis
Kezic S, de Boer F, Metwally NKA, Vlugt KG, Beers-Stet FS, Ouwerkerk W, Jakasa I, Rustemeyer T, van der Molen HF.   +8 more
europepmc   +1 more source

Impact of single-cell cell cycle regulation of intercellular communication on the prognosis of hepatocellular carcinoma in the tumor microenvironment. [PDF]

Clin Exp Med
Hu C, Deng R, Nong S, Mou X.
europepmc   +1 more source

RMzyme: regulations of RNA-modifying enzymes in humans. [PDF]

Signal Transduct Target Ther
Luo R, Xu H, Zhou Q, Ding S, Qiang M, Wen J, Kim P, Yang X, Cai Y, Xie K, Zhu J, Xu Y, Lan T, Zhou X, Wu H.   +14 more
europepmc   +1 more source

Low-dimensional signatures of neuronal activity associated with long-term operant conditioning in Aplysia. [PDF]

Commun Biol
Vanaki S, Gonzalez NO, Neveu CL, Momohara Y, Aazhang B, Byrne JH.   +5 more
europepmc   +1 more source

The evolution of gene regulation in mammalian cerebellum development. [PDF]

Science
Sarropoulos I, Sepp M, Yamada T, Schäfer PSL, Trost N, Schmidt J, Schneider C, Drummer C, Mißbach S, Taskiran II, Hecker N, Bravo González-Blas C, Frömel R, Joshi P, Leushkin E, Arnskötter F, Leiss K, Okonechnikov K, Lisgo S, Palkovits M, Pääbo S, Cardoso-Moreira M, Kutscher LM, Behr R, Pfister SM, Aerts S, Kaessmann H.   +26 more
europepmc   +1 more source

Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations. [PDF]

Nat Commun
Lu T, Hamidi H, Socinski MA, Reck M, Cappuzzo F, Barlesi F, Jotte RM, Müller S, Qamra A, Amitai A, Guan X, Fuentes E, Koeppen H, Giltnane JM, Shames DS, Ballinger M, He MX, Wang Y, Srivastava MK, Nabet BY.   +19 more
europepmc   +1 more source